Data updated: Mar 10, 2026
NOVOLOG FLEXTOUCH
INSULIN ASPART RECOMBINANT
Approved 2000-06-07
8
Indications
--
Phase 3 Trials
1
Priority Reviews
25
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2000-06-07
- Routes
- SUBCUTANEOUS
- Dosage Forms
- INJECTABLE
NOVOLOG FLEXTOUCH Approval History
Loading approval history...
What NOVOLOG FLEXTOUCH Treats
8 FDA approvalsOriginally approved for its first indication in 2000 . Covers 8 distinct patient populations.
- Other (8)
Other
(8 approvals)- • Approved indication (Jun 2000)Label Letter
- • Approved indication (Dec 2001)Label
- • Approved indication (Dec 2002)Label Letter
- • Approved indication (Sep 2005) PriorityLabel Letter
- • Approved indication (Oct 2005)Label
- • Approved indication (Jan 2007)Label Letter
- • Approved indication (Mar 2008)Label Letter
- • Approved indication (Jan 2015)Label Letter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NOVOLOG FLEXTOUCH FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.